Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Interferon α2b Gel (post-change vs pre-change) in Herpes Zoster
CTR20230770Phase 3Completed
- Sponsor
- Zhaoke Pharmaceutical (Hefei) Co., Ltd.
- Start
- Mar 2023
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of antiviral lozenge in herpes zoster (HZ), sponsored by Zhaoke Pharmaceutical (Hefei) Co., Ltd.. Started Mar 2023; status: completed.
02
Drugs
antiviral lozenge
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on CTR20230770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230770.